Application 220366
- Type
- ANDA
- Sponsor
- STERANCO HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LACOSAMIDE | LACOSAMIDE | SOLUTION;ORAL | 10MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220366-001 | LACOSAMIDE | LACOSAMIDE | 10MG/ML | SOLUTION / ORAL | 2026-05-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220366-001 | LACOSAMIDE | 10MG/ML | SOLUTION / ORAL | 2026-05-21 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A220366-001 | LACOSAMIDE | 10MG/ML | SOLUTION / ORAL | 2026-05-21 | caaa826d4ba7… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220366-001 | LACOSAMIDE | 10MG/ML | SOLUTION / ORAL | AA | 2026-05-21 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220366-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lacosamide Oral Solution | LACOSAMIDE | Chartwell Governmental & Specialty RX, LLC. | e265fd09-8149-4423-a317-5760d34b8e9b | 2026-02-25 | Warnings, Adverse reactions | LACOSAMIDE |
| Lacosamide | LACOSAMIDE | Kanchan Healthcare Inc | 41f02424-231d-4039-a122-df4b49dc9998 | 2026-01-29 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
| LACOSAMIDE | LACOSAMIDE | Anthea Pharma Private Limited | b4f2620a-2047-4b33-bb75-18702f6c55e6 | 2026-01-24 | Warnings, Adverse reactions | LACOSAMIDE LACOSAMIDE |
| LACOSAMIDE | LACOSAMIDE | GLENMARK PHARMACEUTICALS INC., USA | bc7ed8a6-acce-48f2-9ef1-4e366c71dbbc | 2026-01-24 | Warnings, Adverse reactions | LACOSAMIDE LACOSAMIDE |
| LACOSAMIDE | LACOSAMIDE | Virtus Pharmaceuticals, LLC | 01162e2f-967b-4596-8188-c0d9889c3814 | 2026-01-23 | Warnings, Adverse reactions | LACOSAMIDE LACOSAMIDE |
| Lacosamide | LACOSAMIDE | Sintetica US LLC | 08ac486a-4f61-4e9e-9683-d1a66a6c2a4d | 2026-01-04 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
| Lacosamide Oral Solution | LACOSAMIDE | Ajenat Pharmaceuticals LLC | cb29da34-89aa-405a-8fbc-2308bda37187 | 2025-12-29 | Warnings, Adverse reactions | LACOSAMIDE |
| lacosamide | LACOSAMIDE | Glenmark Pharmaceuticals Inc. USA | df1d2e6a-6129-49c9-b2c1-0fdf73f38b9c | 2025-12-17 | Warnings, Adverse reactions | lacosamide LACOSAMIDE |
| Lacosamide Oral Solution | LACOSAMIDE | Kesin Pharma Corporation | 446f14be-5d79-26b9-e063-6294a90ae0b5 | 2025-11-25 | Warnings, Adverse reactions | LACOSAMIDE |
| LACOSAMIDE | LACOSAMIDE | ScieGen Pharmaceuticals Inc | f4ffa3ad-1278-4772-9ef8-ed6fdaa47605 | 2025-10-31 | Warnings, Adverse reactions | LACOSAMIDE LACOSAMIDE |
| Lacosamide | LACOSAMIDE | Kanchan Healthcare Inc | 5c03b90e-6985-4005-b6c5-44626d0600d7 | 2025-10-19 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
| Lacosamide | LACOSAMIDE | NorthStar RxLLC | 9dffda6c-9e44-478f-9e02-9da3ab4c50e1 | 2025-10-05 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
| Lacosamide | LACOSAMIDE | Camber Pharmaceuticals, Inc. | bbd80370-3d23-41f8-8914-c6ea897c0154 | 2025-09-29 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
| Lacosamide | LACOSAMIDE | Ascend Laboratories, LLC | 9d7fde23-dc3f-41e9-89cf-6a1a9eeaa7de | 2025-08-11 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
| Lacosamide Oral Solution | LACOSAMIDE | Kesin Pharmaceutical Corporation | 3ba29442-4e8a-c2b2-e063-6294a90a1bbf | 2025-08-05 | Warnings, Adverse reactions | LACOSAMIDE |
| Lacosamide | LACOSAMIDE | Westminster Pharmaceuticals, LLC | 61e3747a-3957-4840-81f0-313aefbd5d2b | 2025-07-29 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
| MOTPOLY XR | LACOSAMIDE | Aucta Pharmaceuticals, Inc. | fb8235b4-4cd3-6f22-e053-6294a90a545c | 2025-07-16 | Warnings, Adverse reactions | LACOSAMIDE |
| Lacosamide | LACOSAMIDE | ANI Pharmaceuticals, Inc. | 68033c90-d9cc-4d5f-896c-9a61a0c3b529 | 2025-06-25 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
| Lacosamide | LACOSAMIDE | Advanced Rx of Tennessee, LLC | 325df1b7-4908-0c03-e063-6294a90ad844 | 2025-04-09 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
| LACOSAMIDE | LACOSAMIDE | Precision Dose, Inc. | fe24b28b-ca15-4dfd-a198-53cdc2c8cb99 | 2025-03-31 | Warnings, Adverse reactions | LACOSAMIDE LACOSAMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.